91黑料

Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    91黑料 provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    91黑料 and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    91黑料's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos
    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    FSA_thumbnail
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    91黑料 regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    Watch the webinar.

    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

  • 91黑料
    91黑料
    Company history 91黑料 at a glance 91黑料 in Asia Pacific 91黑料 in Latin America Leadership Quality
    91黑料 for
    Investigators Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    91黑料 Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    91黑料 at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Contact
  1. Home
  2. Insights

91黑料 Insights

BioPharma companies and Medical Device manufacturers face growing operational, regulatory and economic challenges. 91黑料 provides analysis and key insights on these challenges, with practical advice and recommendations.

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

  • Digital Disruption Technologies that accelerate and improve clinical trials.
  • Patient Centricity Patients are now better informed on clinical options than they ever have been.
  • Regulatory intelligence Regulatory experts partnering with you.
  • Therapeutics insights Thought leadership from 91黑料's global team of therapeutic experts.
  • Transforming Trials The traditional clinical development model needs to change.
  • Value Based Development The traditional healthcare delivery model is changing.

Digital Disruption

Technologies that accelerate and improve clinical trials.

Explore

Patient Centricity

Patients are now better informed on clinical options than they ever have been.

Explore

Regulatory intelligence

Regulatory experts partnering with you.

Explore

Therapeutics insights

Thought leadership from 91黑料's global team of therapeutic experts.

Explore

Transforming Trials

The traditional clinical development model needs to change.

Explore

Value Based Development

The traditional healthcare delivery model is changing.

Explore
Blog
  • 31 Mar 2026

A framework for pediatric HRQoL selection: Evaluating the PedsQL?

blog
  • 20 Mar 2026

Why incorporating GMP and USP is best practice for early phase trials

blog
  • 13 Mar 2026

Lessons learned in EU HTA Regulation’s first year

blog
  • 12 Mar 2026

The future of multiple sclerosis care: Progression focused therapies and real world evidence

blog
  • 09 Mar 2026

The future of clinical data science

blog
  • 19 Feb 2026

Opportunities in bile sampling for human ADME

web-banner
  • 05 Feb 2026

Advancing patient-centred outcomes in sleep medicine

banner
  • 05 Feb 2026

Managing AI model biases in AI-enabled SaMDs

View all blog posts

What’s happening in 91黑料

Site Branding
    91黑料 plc
  • Contact
  • 91黑料
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
91黑料 for
  • Investigators
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials

Legal Footer

  • ? 2026 91黑料 plc
  • Privacy & Data
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence